Masitinib for treatment of severely symptomatic indolent...

The Lancet 2017 / 02 Vol. 389; Iss. 10069

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Lortholary, Olivier, Chandesris, Marie Olivia, Livideanu, Cristina Bulai, Paul, Carle, Guillet, Gérard, Jassem, Ewa, Niedoszytko, Marek, Barete, Stéphane, Verstovsek, Srdan, Grattan, Clive, Damaj, Gan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
389
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)31403-9
Date:
February, 2017
File:
PDF, 364 KB
english, 2017
Conversion to is in progress
Conversion to is failed